Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer.
暂无分享,去创建一个
F. D. De Braud | G. Pruneri | A. Vingiani | L. Castagnoli | C. Vernieri | S. Pupa | R. Lobefaro | F. Ligorio | E. Zattarin | Ilaria Pellegrini | Marzia Santamaria | Claudio Vernieri